For example, IRS 954 (a TLR7/TLR9 inhibitor) has been reported to have a potential in reducing pathogenesis of autoantibody production and autoimmune tissue injury in SLE, another autoimmune disease associated with EBV [30]. The gene discussed is TLR7; the disease is autoimmune disease.